Assessing physician preferences on future therapeutic options and diagnostic practices in non-alcoholic steatohepatitis.

Cook, Nigel; Geier, Andreas; Schmid, Andreas; Hirschfield, Gideon; Kautz, Achim; Schattenberg, Jörn M; Balp, Maria-Magdalena

Cook, Nigel; Geier, Andreas; Schmid, Andreas; Hirschfield, Gideon; Kautz, Achim; Schattenberg, Jörn M; Balp, Maria-Magdalena.

Afiliación

Cook N; Novartis Pharma AG, Basel, Switzerland.
Geier A; Division of Hepatology, University Hospital Würzburg, Würzburg, Germany.
Schmid A; Health Management, School of Law and Economics, University of Bayreuth, Bayreuth, Germany.
Hirschfield G; Toronto Centre for Liver Disease, University Health Network and University of Toronto, Toronto, Canada.
Kautz A; Leberhilfe Projekt gUG, Dülken Straße 9, 51143 Köln, Germany.
Schattenberg JM; Metabolic Liver Research Program, I. Department of Medicine, University Medical Center Mainz, Langenbeckstrasse 1, 55116 Mainz, Germany.
Balp MM; Novartis Pharma AG, Basel, Switzerland.

JHEP Rep ; 2(2): 100081, 2020 Apr.

Article en En | MEDLINE | ID: mdl-32190823

Palabras clave

ACBC, adaptive choice-based conjoint; BWS, best-worst scaling; Best-worst scaling; GPs, general practitioners; HB, hierarchical Bayesian; HTA, health technology assessment; Hb1Ac, glycated haemoglobin; NAFLD; NASH; NASH, non-alcoholic steatohepatitis; Non-invasive diagnostics; PCPs, primary care physicians; SC, steering committee; liver biopsy; liver disease; non-alcoholic fatty liver disease; type 2 diabetes mellitus

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Diagnostic_studies / Guideline / Health_technology_assessment / Prognostic_studies / Qualitative_research Aspecto: Patient_preference Idioma: En Revista: JHEP Rep Año: 2020 Tipo del documento: Article País de afiliación: Suiza Pais de publicación: Países Bajos

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google